Search research articles
Contact Us
Filters
Showing results (281-290 of 373) with videos related to
Page
of 38
Sort By:
JAMA Ophthalmology
|
May 6, 2021
Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial
Adam R Glassman, Wesley T Beaulieu, Maureen G Maguire, et al.
Ophthalmology. Retina
|
June 14, 2021
Predominantly Persistent Subretinal Fluid in the Comparison of Age-Related Macular Degeneration Treatments Trials
Jason Q Core, Maxwell Pistilli, Ebenezer Daniel, et al.
Ophthalmology
|
January 13, 2017
Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials
Juan E Grunwald, Maxwell Pistilli, Ebenezer Daniel, et al.
BMJ Open Ophthalmology
|
June 6, 2023
Prevalence and factors associated with optic disc grey crescent in the Primary Open-Angle African Ancestry Glaucoma Genetics (POAAGG) Study
Ebenezer Daniel, Jinpeng Gao, Maureen G Maguire, et al.
Ophthalmology
|
April 22, 2024
Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies: A Report by the American Academy of Ophthalmology
Justine R Smith, Jennifer E Thorne, Christina J Flaxel, et al.
Cornea
|
September 24, 2013
Assessment of signs of anterior blepharitis using standardized color photographs
Vatinee Y Bunya, David H Brainard, Ebenezer Daniel, et al.
Cornea
|
July 23, 2021
Correlation of Measures From the OCULUS Keratograph and Clinical Assessments of Dry Eye Disease in the Dry Eye Assessment and Management Study
John E Sutphin, Gui-Shuang Ying, Vatinee Y Bunya, et al.
Ophthalmology
|
October 11, 2012
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration
Gui-shuang Ying, Jiayan Huang, Maureen G Maguire, et al.
Ophthalmology. Retina
|
June 17, 2017
Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments Trials
Ebenezer Daniel, Juan E Grunwald, Benjamin J Kim, et al.
Ophthalmology
|
May 14, 2020
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)
Adam R Glassman, John A Wells, Kristin Josic, et al.
Page
of 38
Search research articles
Search
Showing results (281-290 of 373) with videos related to
Sort By:
Page
of 38
JAMA Ophthalmology
|
May 6, 2021
Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial
Adam R Glassman, Wesley T Beaulieu, Maureen G Maguire, et al.
Ophthalmology. Retina
|
June 14, 2021
Predominantly Persistent Subretinal Fluid in the Comparison of Age-Related Macular Degeneration Treatments Trials
Jason Q Core, Maxwell Pistilli, Ebenezer Daniel, et al.
Ophthalmology
|
January 13, 2017
Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials
Juan E Grunwald, Maxwell Pistilli, Ebenezer Daniel, et al.
BMJ Open Ophthalmology
|
June 6, 2023
Prevalence and factors associated with optic disc grey crescent in the Primary Open-Angle African Ancestry Glaucoma Genetics (POAAGG) Study
Ebenezer Daniel, Jinpeng Gao, Maureen G Maguire, et al.
Ophthalmology
|
April 22, 2024
Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies: A Report by the American Academy of Ophthalmology
Justine R Smith, Jennifer E Thorne, Christina J Flaxel, et al.
Cornea
|
September 24, 2013
Assessment of signs of anterior blepharitis using standardized color photographs
Vatinee Y Bunya, David H Brainard, Ebenezer Daniel, et al.
Cornea
|
July 23, 2021
Correlation of Measures From the OCULUS Keratograph and Clinical Assessments of Dry Eye Disease in the Dry Eye Assessment and Management Study
John E Sutphin, Gui-Shuang Ying, Vatinee Y Bunya, et al.
Ophthalmology
|
October 11, 2012
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration
Gui-shuang Ying, Jiayan Huang, Maureen G Maguire, et al.
Ophthalmology. Retina
|
June 17, 2017
Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments Trials
Ebenezer Daniel, Juan E Grunwald, Benjamin J Kim, et al.
Ophthalmology
|
May 14, 2020
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)
Adam R Glassman, John A Wells, Kristin Josic, et al.
Page
of 38